Medical Marijuana Launches Pharma Subsidiary In Brazil, Expanding Access To CBD Products In Pharmacies

Medical Marijuana, Inc. MJNA has launched its first pharmaceutical subsidiary, HM Pharma, in Brazil.

“We have been working hard to connect and build meaningful relationships with medical professionals and consumers in Brazil. This new sales channel will open new avenues for continued growth by bringing our cannabidiol (CBD) products to pharmacies throughout the country,” said Matheus Patelli, managing director of HM Pharma. “Not only will our products be more affordable than other CBD products sold at drugstores in Brazil, but they will be of the highest quality.”

In Brazil, CBD is currently permitted only for medical use with authorization from the country’s National Sanitary Surveillance Agency (Anvisa). HM Pharma will operate under Anvisa Normative 327/2019 which allows the company to sell its products in pharmacies. Customers will soon have the choice to purchase HM Pharma in a pharmacy at the point of sale with a doctor’s prescription or continue to order from HempMeds® Brasil using Brazil’s Compassionate Use law. The company expects that HM Pharma products will be on pharmacy shelves by the end of 2022.

Medical Marijuana, Inc. subsidiary HempMeds Brasil was the first company to legally import products to Brazil in 2015 utilizing Brazil’s Compassionate Use laws. The compassionate use market in Brazil is thriving and it will continue to coexist with the medical market. HempMeds Brasil will continue to operate under the compassionate use model, while HM Pharma will operate under Anvisa Normative 327/2019.

“HempMeds Brazil has imported over 150 thousand prescription products to Brazil through the compassionate model since 2015, and we continue to grow at an average rate of 50% yearly. Our market leadership reflects the quality of our products, customer care and doctor relationships,” added Patelli.

Related Links:

Medical Marijuana, Inc. Reports Revenue Of $7.8M For Q1 2022

Medical Marijuana Subsidiary Kannaway Reports Largest Revenue In Company History For South Africa Division

Photo: Courtesy of Mike Swigunski on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsMatheus Patelli
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.